bifido

Bifidobacterium bifidum

BGN4

Immune modulating Bifidobacterium
strain with high adhesion activity.

  • Isolated from the feces of healthy breast-feeding infants
  • US FDA GRAS Notification GRN No. 814
  • Deposited at the Korean Culture Center of Microbiology as KCCM 80046
  • KR Patented / Complete genomic sequenced
    (GenBank no. CP001361)

Bio-functional
effects

Bifidobacterium bifidum BGN4 was found to produce chiroinositol-containing polysaccharide (BB-pol), which showed anti-tumor activity on human colon cancer cell lines.

GUT

  • · Immune PDF
  • · Diarrhea PDF
  • · Ulcerative colitis PDF
  • · IBS PDF

BRAIN

  • · Cognitive function PDF
  • · State of emotion PDF

KIDNEY

SKIN

  • · Eczema PDF

Global
Notifications

Featured in
book chapters

B. bifidum BGN4, originated from a breast fed infant, is well documented regarding clinical evidence for its health promoting effects by various researchers of universities and hospitals and have been featured in the international textbooks of microbiology.

Global
application

More
References

Certificate

  • • Non-GMO
  • • BSE-free
  • • TSE-free
  • • No Allergen
  • • Halal Certi

Packaging

  • • 1kg / pack
  • • 10pack/box

Safety

  • • US FDA GRAS approved
  • • US FDA NDI approved
  • • Whole Genome Sequencing
  • • 30 years without side effect

Storage Condition

Be kept in an airtight container
and stored at a temperature not
exceeding 8℃

top으로 이동